U.S. markets closed

Cytosorbents Corporation (CTSO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
7.00-0.26 (-3.58%)
At close: 4:00PM EDT
7.00 0.00 (0.00%)
After hours: 05:08PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
As of Date: 8/5/2021
Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 7

Trading Information

Stock Price History

Beta (5Y Monthly) 0.28
52-Week Change 3-23.66%
S&P500 52-Week Change 332.07%
52 Week High 311.68
52 Week Low 37.00
50-Day Moving Average 37.69
200-Day Moving Average 38.77

Share Statistics

Avg Vol (3 month) 3240.89k
Avg Vol (10 day) 3156.28k
Shares Outstanding 543.32M
Implied Shares Outstanding 6N/A
Float 39.65M
% Held by Insiders 18.47%
% Held by Institutions 143.14%
Shares Short (Jul 14, 2021) 42.2M
Short Ratio (Jul 14, 2021) 46.35
Short % of Float (Jul 14, 2021) 45.18%
Short % of Shares Outstanding (Jul 14, 2021) 45.08%
Shares Short (prior month Jun 14, 2021) 42.11M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:25
Last Split Date 3Dec 04, 2014

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021


Profit Margin -19.94%
Operating Margin (ttm)-25.05%

Management Effectiveness

Return on Assets (ttm)-10.20%
Return on Equity (ttm)-17.35%

Income Statement

Revenue (ttm)42.9M
Revenue Per Share (ttm)1.04
Quarterly Revenue Growth (yoy)21.70%
Gross Profit (ttm)29.95M
EBITDA -10.11M
Net Income Avi to Common (ttm)-8.55M
Diluted EPS (ttm)-0.21
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)68.47M
Total Cash Per Share (mrq)1.58
Total Debt (mrq)923.96k
Total Debt/Equity (mrq)1.20
Current Ratio (mrq)8.16
Book Value Per Share (mrq)1.78

Cash Flow Statement

Operating Cash Flow (ttm)-4.75M
Levered Free Cash Flow (ttm)-2.3M